Assessment of the analgesic effect of centhaquin in mouse tail flick and hot-plate tests

Pharmacology

Volumn 88, Issue 5-6, 2011, Pages 233-241

  Andurkar, Shridhar V ^a   Gulati, Anil ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Adrenergic receptors; Analgesia; Centhaquin; Endothelin receptors; Hot plate test; Imidazoline receptors; Opioid receptors; Tail flick test

Indexed keywords

CENTHAQUIN; MORPHINE SULFATE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; HOT PLATE TEST; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; ANTIHYPERTENSIVE AGENTS; BODY TEMPERATURE; DRUG INTERACTIONS; HOT TEMPERATURE; IDAZOXAN; IMIDAZOLINE RECEPTORS; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN; PIPERAZINES; RECEPTOR, ENDOTHELIN A; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, OPIOID; YOHIMBINE;

EID: 80053895117     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000331880     Document Type: Article

References (45)

1. Murthi VA, Jain PC, Sharma JN, Srimal RC, Dhawan BN, Anand N: 1-substituted 4-(α-2- quinolylethyl)piperazines and 1,2,3,4- tetrahydroquinolyl- ethyl analogues thereof. US patent No 3,983,121. 1976. http://xrint.com/ patents/us.
2. Bajpai UC, Gupta DC, Singh RB, Saxena M, Saxena AK: Fourier transform infrared spectra and normal mode analysis of 1-(3-methylphenyl piperazin-1-yl)-2- (quinolin-2-yl)ethane (centhaquin): A potent centrally acting anti-hypertensive agent. J Mol Struct 2000; 516: 15-21. (Pubitemid 30014336)
3. Carpy A, Saxena AK: Structure of 1-(3-methylphenyl)-4-(2-beta- quinolylethyl) piperazine: Centhaquin. Acta Crystallogr 1991;C47: 227-229.
4. Murti A, Bhandari K, Ram S, Prabhakar YS, Saxena AK, Jain PC, Gulati AK, Srimal RC, Nityanand S, Anand N: Synthesis and QSAR of 1-aryl-4-(α-2- quinolyl/1-isoquinolylethyl) piperazines and some related compounds as hypotensive agents. Indian J Chem 1989; 28B:934-942. (Pubitemid 19256974)
5. Srimal RC, Gulati K, Nityanand S, Dhawan BN: Pharmacological studies on 2-[2-(4-[3-methylphenyl]-1-piperazinyl)ethyl] quinoline (centhaquin). I. Hypotensive activity. Pharmacol Res 1990; 22: 319-329. (Pubitemid 20377025)
6. Gulati A, Hussain G, Srimal RC: Effect of repeated administration of centhaquin, a centrally acting hypotensive drug, on adrenergic, cholinergic (muscarinic), dopaminergic, and serotonergic receptors in brain-regions of rat. Drug Dev Res 1991; 23: 307-323.
7. Gulati A, Hussain G, Srimal RC: Effect of repeated administration of clonidine on adrenergic, cholinergic (muscarinic), dopaminergic, and serotonergic receptors in brainregions of rat. Drug Dev Res 1991; 22: 141-152.
8. Gulati A, Arora RC, Crayton J: Central serotonergic uptake mechanisms in hypertensive rats: Effects of clonidine and centhaquin. Eur J Pharmacol 1993; 231: 151-156. (Pubitemid 23050894)
9. Paalzow L: Analgesia produced by clonidine in mice and rats. J Pharm Pharmacol 1974; 26: 361-363.
10. Boxwalla M, Matwyshyn G, Puppala BL, Andurkar SV, Gulati A: Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole. Can J Physiol Pharmacol 2010; 88: 541-552.
11. Bhalla S, Andurkar SV, Gulati A: Study of adrenergic, imidazoline, and endothelin receptors in clonidine-, morphine-, and oxycodone- induced changes in rat body temperature. Pharmacology 2011; 87: 169-179.
12. Quail MT, Shannon M: Severe hypothermia caused by clonidine. Am J Emerg Med 2003; 21: 86.
13. Livingston A, Low J, Morris B: Effects of clonidine and xylazine on body temperature in the rat. Br J Pharmacol 1984; 81: 189-193. (Pubitemid 14148332)
14. Aley KO, Levine JD: Multiple receptors involved in peripheral a 2, m , and a1 antinociception, tolerance, and withdrawal. J Neurosci 1997; 17: 735-744. (Pubitemid 27024585)
15. Calvillo O, Ghignone M: Presynaptic effect of clonidine on unmyelinated afferent fibers in the spinal cord of the cat. Neurosci Lett 1986; 64: 335-339. (Pubitemid 16163834)
16. Ono H, Mishima A, Ono S, Fukuda H, Vasko MR: Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alphaadrenergic receptor antagonists. Neuropharmacology 1991; 30: 585-589.
17. Chan MF, Okun I, Stavros FL, Hwang E, Wolff ME, Balaji VN: Identification of a new class of eta selective endothelin antagonists by pharmacophore directed screening. Biochem Biophys Res Commun 1994; 201: 228-234.
18. Spaulding TC, Fielding S, Venafro JJ, Lal H: Antinociceptive activity of clonidine and its potentiation of morphine analgesia. Eur J Pharmacol 1979; 58: 19-25. (Pubitemid 9232925)
19. Vercauteren MP, Saldien V, Bosschaerts P, Adriaensen HA: Potentiation of sufentanil by clonidine in PCEA with or without basal infusion. Eur J Anaesthesiol 1996; 13: 571-576. (Pubitemid 26402383)
20. Gulati A, Bhalla S, Matwyshyn G, Zhang Z, Andurkar SV: Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874. Pharmacology 2009; 83: 45-58.
21. Meert TF, De Kock M: Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats. Anesthesiology 1994; 81: 677-688. (Pubitemid 24320678)
22. McCleane G: Pharmacological management of neuropathic pain. CNS Drugs 2003; 17: 1031-1043. (Pubitemid 37463821)
23. Knotkova H, Pappagallo M: Adjuvant analgesics. Med Clin North Am 2007; 91: 113-124. (Pubitemid 44883352)
24. Gurtu S, Shukla S, Mukerjee D: Morphine, clonidine coadministration in subanalgesic doses: Effective control of tonic pain. Neuroreport 1994; 5: 715-717. (Pubitemid 24110363)
25. Nader ND, Li CM, Dosluoglu HH, Ignatowski TA, Spengler RN: Adjuvant therapy with intrathecal clonidine improves postoperative pain in patients undergoing coronary artery bypass graft. Clin J Pain 2009; 25: 101-106.
26. Mackenzie JW: Acute pain management for opioid dependent patients. Anaesthesia 2006; 61: 907-908. (Pubitemid 44219467)
27. Raith K, Hochhaus G: Drugs used in the treatment of opioid tolerance and physical dependence: A review. Int J Clin Pharmacol Ther 2004; 42: 191-203. (Pubitemid 38477435)
28. Devenyi P, Mitwalli A, Graham W: Clonidine therapy for narcotic withdrawal. Can Med Assoc J 1982; 127: 1009-1011. (Pubitemid 13253304)
29. Gowing L, Farrell M, Ali R, White JM: Alpha2-Adrenergic agonists for the management of opioid withdrawal. Cochrane Database Syst Rev 2009; 2:CD002024.
30. Honey BL, Benefield RJ, Miller JL, Johnson PN: Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother 2009; 43: 1506-1511.
31. Junnarkar AY, Singh PP: Antagonism of clonidine-induced hypothermia by alpha adrenoceptor antagonists in electrically stimulated mice. Pharmacol Res Commun 1988; 20: 451-463.
32. Biancalani C, Giovannoni MP, Pieretti S, Cesari N, Graziano A, Vergelli C, Cilibrizzi A, Di Gianuario A, Colucci M, Mangano G, Garrone B, Polenzani L, Dal Piaz V: Further studies on arylpiperazinyl alkyl pyridazinones: Discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. J Med Chem 2009; 52: 7397-7409.
33. Bhalla S, Matwyshyn G, Gulati A: Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists. Brain Res 2005; 1064: 126-135. (Pubitemid 41774652)
34. D'Amour FE, Smith DL: A method of determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-79.
35. Eddy NB, Leimbach D: Synthetic analgesics. II. Dithienylbutenyl-And dithienylbutylamines. J Pharmacol Exp Ther 1953; 107: 385-393.
36. McLennan PL: The hypothermic effect of clonidine and other imidazolidines in relation to their ability to enter the central nervous system in mice. Eur J Pharmacol 1981; 69: 477-482. (Pubitemid 11137154)
37. Solomon RE, Brody MJ, Gebhart GF: Pharmacological characterization of alpha adrenoceptors involved in antinociceptive and cardiovascular effects of intrathecally administered clonidine. J Pharmacol Exp Ther 1989; 251: 27-38. (Pubitemid 19261942)
38. Li JX, Zhang Y: Imidazoline I2 receptors: Target for new analgesics? Eur J Pharmacol 2011; 658: 49-56.
39. Vilardaga J-P, Nikolaev VO, Lorenz K, Ferrandon S, Zhuang Z, Lohse MJ: Conformational cross-talk between 2A-adrenergic andα-opioid receptors controls cell signaling. Nat Chem Biol 2008; 4: 126-131.
40. Roerig SC, Lei S, Kitto K, Hylden KKL, Wilcox GL: Spinal interactions between opioid and noradrenergic agonists in mice: Multiplicativity involves delta and alpha-2 receptor. J Pharmacol Exp Ther 1992; 262: 365-374.
41. Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA: Functional interactions betweenα-opioid and 2A-adrenergic receptors. Mol Pharmacol 2003; 64: 1317-1324. (Pubitemid 37532221)
42. Bhalla S, Matwyshyn G, Gulati A: Potentiation of morphine analgesia by BQ123, an endothelin antagonist. Peptides 2002; 23: 1837-1845. (Pubitemid 35279842)
43. Gulati A, Bhalla S, Matwyshyn G: A novel combination of opiates and endothelin antagonists to manage pain without any tolerance development. J Cardiovasc Pharmacol 2004; 44:S129-S131. (Pubitemid 40039661)
44. Bhalla S, Ciaccio N, Wang ZJ, Gulati A: Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells. Exp Biol Med 2006; 231: 1152-1156. (Pubitemid 43845595)
45. Bhalla S, Matwyshyn G, Gulati A: Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats. Peptides 2003; 24: 553-561. (Pubitemid 36829344)